Literature DB >> 22759956

AMP converted from intracellularly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis.

Yoshitaka Nogi1, Takeshi Kanno, Takashi Nakano, Yumiko Fujita, Chiharu Tabata, Kazuya Fukuoka, Akinobu Gotoh, Tomoyuki Nishizaki.   

Abstract

BACKGROUND/AIMS: The present study investigated adenosine-induced apoptosis in human malignant pleural mesothelioma cells.
METHODS: MTT assay, TUNEL staining, flow cytometry using propidium iodide and annexin V-FITC, real-time RT-PCR, Western blotting, and assay of caspase-3, -8, and -9 activities were carried out using malignant pleural mesothelioma cell lines such as NCI-H28, NCI-H2052, NCI-H2452, and MSTO-211H cells, and p53 or A(3) adenosine receptor was knocked-down by transfecting each siRNA into cells.
RESULTS: Adenosine induced apoptosis in all the malignant pleural mesothelioma cells used here, independently of caspase activation. The adenosine effect was prevented by the adenosine transporter inhibitor dipyridamole, the adenosine kinase inhibitor ABT-702, or the A(3) adenosine receptor inhibitor MRS1191. Adenosine upregulated expression of the p53 mRNA and protein, that is abolished by ABT-702, but not by knocking-down A(3) adenosine receptor. Adenosine-induced apoptosis in NCI-H28 cells was significantly inhibited by knocking-down p53 and in part by knocking-down A(3) adenosine receptor.
CONCLUSION: The results of the present study show that AMP converted from intracellularly transported adenosine upregulates p53 expression to induce caspase-independent apoptosis in malignant pleural mesothelioma cells and that A(3) adenosine receptor also participates partially in the apoptosis by the different mechanism.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759956     DOI: 10.1159/000339048

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

Review 1.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer.

Authors:  Saly Al-Taei; Josephine Salimu; Lisa K Spary; Aled Clayton; Jason F Lester; Zsuzsanna Tabi
Journal:  Oncoimmunology       Date:  2016-12-08       Impact factor: 8.110

Review 3.  Adenosinergic signaling as a target for natural killer cell immunotherapy.

Authors:  Jiao Wang; Sandro Matosevic
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

Review 4.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

Review 5.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

Review 6.  Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.

Authors:  Paola de Andrade Mello; Robson Coutinho-Silva; Luiz Eduardo Baggio Savio
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

7.  Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.

Authors:  Paola de Andrade Mello; Eduardo Cremonese Filippi-Chiela; Jéssica Nascimento; Aline Beckenkamp; Danielle Bertodo Santana; Franciele Kipper; Emerson André Casali; Alessandra Nejar Bruno; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Marcia Rosângela Wink; Guido Lenz; Andréia Buffon
Journal:  Mol Biol Cell       Date:  2014-08-07       Impact factor: 4.138

Review 8.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

9.  Adenosine Suppresses Cholangiocarcinoma Cell Growth and Invasion in Equilibrative Nucleoside Transporters-Dependent Pathway

Authors:  Kornkamon Lertsuwan; Supathra Phoaubon; Nathapol Tasnawijitwong; Jomnarong Lertsuwan
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.